On the reactor-based products and the processing that follows, I hope we'd look to design we'd learned from the lessons of the past. As I said, I think the European experience and the reasons companies like Covidien and Lantheus can interchange is that their European facilities have more flexibility. But I'll let Mr. Littlejohn speak to that.
